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Summary
Cell size control requires mechanisms that integrate cell
growth and division. Key to this integration in fission yeast
is the SAD family kinase Cdr2, which organizes a set of
cortical nodes in the cell middle to promote mitotic entry
through Wee1 and Cdk1 [1–3]. Cdr2 is inhibited by a spatial
gradient of the DYRK kinase Pom1 emanating from cell
tips in a cell-size-dependent manner [2, 3], but how the
Pom1 gradient inhibits Cdr2 activity during cell growth is
unknown. Here, we show that Pom1 acts to prevent activa-
tion of Cdr2 kinase activity by the CaMKK Ssp1. We found
that Ssp1 activates Cdr2 through phosphorylation of a
conserved threonine residue (Thr166) in the activation loop
of the Cdr2 N-terminal kinase domain both in vitro and in
cells. The levels of this activating phosphorylation increased
with cell-cycle progression, and genetic epistasis demon-
strated that Ssp1 promotes mitotic entry through Cdr2.
Intriguingly, Pom1 phosophorylated the C-terminal domain
of Cdr2, and this modification reduced Cdr2-T166 phosphor-
ylation by Ssp1. These findings show how activation of the
conserved mitotic inducer Cdr2 is integrated with an inhibi-
tory spatial gradient to ensure proper cell size control at
mitosis.
Results and Discussion
Many cell types delay cell-cycle transitions until reaching a
critical size threshold, but the mechanisms that sense and
transmit these signals are largely unknown. Fission yeast cells
have a band of cortical nodes in the cell middle; these nodes
contain conserved cell-cycle regulators including Wee1 and
its inhibitors Cdr1 and Cdr2 [1–3]. These proteins are key com-
ponents of the system that prevents mitotic entry until cells
reach a critical and reproducible size. Prior to mitotic entry,
the SAD family kinase Cdr2 organizes node formation and rep-
resents the most upstream component of these structures [2].
Thus, Cdr2 regulatory factors might represent input signals for
the mitotic size control system [4]. Indeed, the DYRK kinase
Pom1 forms a spatial gradient that is proposed to link cell
size with mitotic entry through inhibition of Cdr2. This Pom1-
Cdr2 system has collectively been referred to as the ‘‘cell
geometry network’’ [5, 6]. However, it has been unclear how
Pom1 inhibits Cdr2 function in cells and how this inhibition
might relate to the control of cell size at mitosis by other
Cdr2 regulatory factors. Here, we address these questions*Correspondence: james.b.moseley@dartmouth.eduthrough the identification of a novel activation step for Cdr2
in mitotic entry that is inhibited by Pom1.
Cdr2 Is Activated through T166 Phosphorylation
We identified 16 in vivo phosphorylation sites on Cdr2 as part
of a large-scale SILAC (stable isotope labeling by amino acids
in cell culture)-based phosphoproteomic screen for sub-
strates of Pom1 (Figure 1A and Table S1 available online). In
brief, Pom1 kinase activity was inhibited for 15 min using an
analog-sensitive pom1-as strain. Changes in the phosphopro-
teome were quantified using phosphopeptide enrichment
followed by nanoscale microcapillary liquid chromatography-
tandem mass spectrometry as previously described (see the
Experimental Procedures; the full results of this screen will
be published as a separate study). The C-terminal domain
(CTD) of Cdr2 was phosphorylated in amanner that heavily de-
pended on Pom1, suggesting that this cluster of serine resi-
dues is the primary site of Pom1-dependent regulation in cells.
Consistent with this possibility, purified Pom1 phosphorylated
the Cdr2-CTD directly in vitro (Figure S1A). In contrast, we
found a single residue (Thr166) in the Cdr2 kinase domain
that was more heavily phosphorylated upon inhibition of
Pom1 (Table S1). This suggests that Thr166 is modified by
a different kinase and may be antagonized by Pom1. Thr166
was the only phosphorylation site that we found in the Cdr2
kinase domain and represents a well-conserved feature
of the activation loop (T loop) among AMPK/SNF1-related
kinases from yeast through humans (Figure 1B). This T loop
Thr is present in three additional fission yeast members of
the AMPK/SNF1 protein kinase family, but not in the Cdr2-
related protein kinase Cdr1. T loop phosphorylation by up-
stream kinases is required for the catalytic activity of members
of this protein kinase family [7–11]. Therefore, we decided to
investigate the role of Cdr2-T166 phosphorylation in cells.
To test the physiological role of Cdr2-T166 phosphorylation,
we generated a nonphosphorylatable cdr2-T166Amutant. We
integrated wild-type cdr2+, nonphosphorylatable cdr2-T166A,
and kinase-dead cdr2-E177A constructs at the endogenous
locus using gene replacement. Fission yeast cells reproducibly
enter intomitosis and divide atw14 mm in length, due in part to
regulation of Cdr2.We found that cdr2-T166A cells divided at a
larger size than wild-type cells, reflecting a delay in mitotic en-
try. This defect phenocopied the kinase-dead cdr2-E177A
mutant (and a separate kinase-dead mutant, cdr2-K39R; Fig-
ure S1B), but was not as severe as that in the full cdr2Dmutant
(Figure 1C), consistent with the previously demonstrated
kinase-independent scaffolding function for Cdr2 [1, 2]. Using
integrated GFP tags, we found that both mEGFP-Cdr2-T166A
and Cdr2-E177A-mEGFP localized to cortical nodes in the cell
middle, similar to wild-type mEGFP-Cdr2 (Figure 1D). This
contrasts with the budding yeast Cdr2-like kinase Hsl1, which
requires autophosphorylation for proper localization [12].
Similar to kinase-dead mutations [2], cdr2-T166A did not
disrupt localization of downstream node components (Fig-
ure S1C). These combined results suggest that Thr166 phos-
phorylation is required for Cdr2 kinase activity in cells, similar
to other members of the AMPK/SNF1 protein kinase family.
Loss of kinase activity in the cdr2-T166A or cdr2-E177A
Figure 1. Cdr2 Promotes Mitotic Entry through
Activation of T166 Phosphorylation
(A) Schematic of Cdr2 structure and phosphory-
lation map. Pom1-dependent sites are high-
lighted. KA1, kinase associated-1 domain; CTD,
C-terminal domain.
(B) Sequence alignment of activation loops for
Cdr2 and related kinases. The asterisk marks
the conserved threonine; identical residues
are shown in black. Sc., Saccharomyces cerevi-
siae; Sp., Schizosaccharomyces pombe; Dm.,
Drosophila melanogaster; Ce., Caenorhabditis
elegans; Hs., Homo sapiens.
(C) Length of dividing, septated cells of the indi-
cated strains (mean 6 SD; n > 50 for each value).
(D) Localization of indicated Cdr2 mutant pro-
teins. Images are inverted maximum projections
from deconvolved z series. Scale bar, 5 mm.
(E) Detection of Cdr2-T166 phosphorylation
using a phosphospecific a-pT166 antibody.
Arrowheads indicate the Cdr2-pT166. Note the
doublets in the wild-type.
(F) Synchronization of 6His2HA-cdr2 cells grown
in YE4S at 30C after centrifugal elutriation. Two
cell cycles were tracked; the septation index
(n > 700) and cell size (n > 250) were measured
on blankophor-stained cells. The dashed lines
indicate the septation peaks.
(G) Western blots of synchronized cells from
120 min to 300 min after elutriation. A wild-type
sample (no tag) was loaded as a control. Total
Cdr2 level was blotted by a-HA, and tubulin
(a-TAT1) was used as a loading control.
(H) Quantification of total Cdr2 and Cdr2-pT166
levels during cell-cycle progression in (G). Values
were normalized by TAT1.
See also Figure S1 and Table S1.
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429mutants does not affect Cdr2 localization, but it delays mitotic
entry, leading to increased cell size at division.
Cell-Cycle Oscillation of Cdr2-T166 Phosphorylation
To probe the cell-cycle timing of Cdr2-T166 phosphorylation,
we generated a phosphospecific antibody against this acti-
vatingmodification. In western blots usingwhole-cell extracts,
the a-pT166 antibody detected a double band at the correct
molecular weight for Cdr2 in wild-type cells, but not in cdr2D
or cdr2-T166A cells (Figure 1E). A size-shifted band was
detected with a-pT166 for mEGFP-Cdr2 due to the GFP tag,
but not for mEGFP-Cdr2-T166A. Further, we performed
in vitro phosphatase assays with immunoprecipitated Cdr2
to confirm the phosphospecificity of a-pT166 (Figure S1D).
Next, we tested the levels of Cdr2-pT166 during cell-cycle
progression. We synchronized cell-cycle progression in
cultures of 6His2HA-cdr2 cells by centrifugal elutriation (Fig-
ures 1F and S1E). The level of Cdr2 protein was constant
throughout the cell cycle, consistent with previous work [13].In contrast, the level of phosphorylated
Cdr2-pT166 was low in small newborn
cells, and then increased during G2 as
cells grew and approached division
(Figure 1G). Cdr2-pT166 levels were
highest 20 min prior to the peak of
septation, which occurred at 240 min
(Figure 1H). This peak in Cdr2-pT166
coincides with loss of Cdk1-Tyr15 phos-
phorylation (Figure S1F), which occursat mitotic entry. We conclude that Cdr2 activation by Thr166
phosphorylation increases as cells grow during G2 phase of
the cell cycle and peaks as cells enter mitosis and divide.
This suggests the existence of a dynamic system that links
this activating modification with the mitotic size control
system.
The CaMKK Ssp1 Phosphorylates Cdr2-Thr166 to Promote
Mitotic Entry
To identify the upstream kinase that activates Cdr2 by phos-
phorylation of Thr166, we screened a collection of 32 nones-
sential protein kinase deletion mutants enriched for potential
links to cell-cycle regulation. We probed whole-cell extracts
for Cdr2-pT166 and found a single mutant, ssp1D, that abol-
ished this modification (Figure 2A). Ssp1 is a conserved
CaMKK (Ca2+/calmodulin-dependent protein kinase kinase)
that has been suggested to promote mitotic entry through un-
known pathways [14, 15]. In diverse cell types and organisms,
CaMKK proteins activate AMPK-related kinases through
Figure 2. CaMKK Ssp1 Promotes Mitotic Entry
by Activating Cdr2
(A) Ssp1 is required for Cdr2-pT166 in cells. Ki-
nase mutant strains were grown in YE4S, and
whole-cell lysates were blotted by a-pT166 anti-
body. Note the absence of Cdr2-pT166 in ssp1D
mutant. Asterisks denote background bands.
(B) Cdr2-pT166 is absent in ssp1D and ssp1-KD
mutants. The indicated whole-cell lysates were
probed by a-pT166 antibody. a-TAT1 was used
as a loading control.
(C) In vitro kinase assays using purified re-
combinant Cdr2 kinase domain (aa 8–263) and
full-length Ssp1.
(D) In vitro kinase assays using purified re-
combinant GST-Cdr2N (aa 1–400) and Ssp1
with g-32P-ATP. Note the loss of 32P incorpora-
tion for T166A mutant.
(E) Length of dividing, septated cells of the indi-
cated strains (mean 6 SD; n > 50 for each value).
The p values of two-tailed Student’s t tests are
indicated in brackets for specific pairs.
(F) Localization of Cdr2 and Cdr2-T166A in ssp1D
cells. Images are inverted maximum projections
from deconvolved z series. Scale bar, 5 mm.
See also Figure S2.
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430phosphorylation. To test the role of Ssp1 kinase activity, we
generated the kinase-dead mutant ssp1-KD with K164A
mutation (Figure S2A). In both ssp1D and ssp1-KD mutants,
Cdr2-pT166 was absent, but total protein levels of Cdr2 were
unchanged from those of the wild-type (Figure 2B). These
results indicate that Ssp1 kinase activity is required for
phosphorylation of Cdr2-T166 in cells. To determine whether
Ssp1 directly phosphorylates Cdr2, we purified recombinant
full-length Ssp1 and Cdr2 kinase domain (aa 8–263) from bac-
teria (Figure S2B) and then performed in vitro kinase assays.
We detected Cdr2-pT166 in the presence but not in the
absence of Ssp1 (Figure 2C), demonstrating that Ssp1 can
directly phosphorylate this residue. Further, the T166A muta-
tion abolished phosphorylation of Cdr2 by Ssp1 in vitro, as
detected by 32P incorporation (Figures 2D and S2C). Based
on these combined results, we conclude that Ssp1 phosphor-
ylates Cdr2-T166 both in vitro and in cells.
We next used genetic epistasis to test the functional role of
Ssp1 in activating Cdr2 for mitotic entry (Figure 2E). Both
ssp1D and cdr2-T166A single mutants were elongated at divi-
sion, consistent with previous work for Ssp1 [14, 15]. These
effects were not additive: the double mutant ssp1D cdr2-
T166A phenocopied the single mutant ssp1D. In contrast,
the mitotic delay of both ssp1D and cdr2-T166A mutantswas additive with mutations in Cdc25,
which promotes mitotic entry through
a separate, parallel pathway [13]. This
suggests that Ssp1 promotes mitosis
through phosphorylation of Cdr2-T166.
To test this possibility further, we gener-
ated a phosphomimetic cdr2-T166E
mutant, which exhibited a small but
reproducible increase in size at divi-
sion, suggesting that it is not fully
functional. Nonetheless, cdr2-T166E
partially suppressed the cell size defect
of ssp1D cells (Figure 2E). Interestingly,
the degree of suppression (3 mm) byphosphomimetic cdr2-T166E correlated with the increase in
cell size by nonphosphorylatable cdr2-T166A. These com-
bined results indicate that Ssp1 promotes mitotic entry in cells
by phosphorylating Cdr2-T166 to ensure proper cell size
control.
Three additional results from our genetic experiments offer
insights into the Ssp1-Cdr2 relationship in cells. First, we
observed a small additive defect in the cdr2D ssp1D double
mutant (Figure 2E), which contrasts with the nonadditive
ssp1D cdr2-T166A double mutant. Second, ssp1D did not
impair the localization of Cdr2 or Cdr2-T166A (Figure 2F).
These two results suggest that Ssp1 acts through Cdr2 kinase
activity independent from Cdr2 scaffolding activity. Finally,
the ssp1D defects are exacerbated under stress conditions
such as high temperature, while cdr2-T166A defects are not
(Figure S2D). This indicates that Ssp1 is likely to activate addi-
tional mitotic regulators beyond Cdr2 under environmental
stress. Ssp1 may link to environmental sensing through its
activation of AMPK Ssp2 [11, 16], as well as other potential
targets.
Spatial Control of the Ssp1-Cdr2 Mitotic Entry System
We next investigated the spatial requirements for Ssp1-Cdr2
regulation in cells. Cdr2 localizes to cortical nodes in the cell
Figure 3. Membrane Localization Is Not
Required for Cdr2 Activation by Ssp1
(A) Localization of Ssp1-mEGFP and Ssp1-
mEGFP-CAAX. Images are inverted, single focal
planes. Scale bar, 5 mm.
(B) Western blots for Cdr2-pT166 for whole-cell
lysates from the indicated strains. The panel on
the right shows quantification of pT166 levels
from three independent experiments with values
normalized to the wild-type. Error bars indicate
the SD.
(C) Localization of mEGFP-tagged Cdr2 mutant
proteins. Images are inverted, single focal
planes. Scale bar, 5 mm.
(D) Detection of Cdr2-pT166 in whole-cell lysates
from Cdr2 mutants. The asterisk denotes back-
ground bands. The panel on the right shows
quantification of pT166 levels in three indepen-
dent experiments with values normalized to the
wild-type. Error bars indicate the SD.
(E) Localization of Ssp1-mEGFP and Cdr2-GBP-
mCherry in the same strain. GBP, GFP binding
peptide.
(F) Detection of Cdr2-pT166 in the indicated
strains.
In (B) and (F), a-TAT1 was used as a loading
control.
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431middle [1]; endogenous Ssp1 has not been examined, but
plasmid-expressed Ssp1 was present in the cytoplasm of un-
stressed cells [14]. We integrated a C-terminal mEGFP tag at
the endogenous ssp1+ locus and found that Ssp1-mEGFP
localized in a diffuse pattern in the cytoplasm (Figure 3A).
Recruitment of Ssp1 to the cell cortex by a lipid-modified
CAAX motif did not increase the level of Cdr2-pT166 (Figures
3A and 3B), suggesting that cytoplasmic Ssp1 performs this
modification.
We tested the role of Cdr2 localization to cortical nodes by
using a truncated cdr2(1-600) construct that lacks the mem-
brane-targeting KA1 domain (kinase associated-1 domain
[17]) and the CTD. Cdr2(1-600)-mEGFP was absent from
cortical nodes and instead localized to the cytoplasm and
nucleus. This contrasts with full-length Cdr2-mEGFP and
mEGFP-Cdr2-T166A, which were present at cortical nodes
and in the cytoplasm (Figure 3C). Despite its removal from
the cell cortex, Cdr2(1-600)-mEGFP was still phosphorylated
at Thr166, though at slightly reduced levels (Figure 3D). We
note that loss of Cdr2-CTD phosphorylation by Pom1 could
also affect pT166 levels in the Cdr2(1-600) construct. These re-
sults suggest a location-independent activation event, similar
to the mechanism proposed for T loop activation of the related
protein kinase Kin4 in budding yeast [7]. We conclude that
Cdr2 cortical localization is not required for activation by
Ssp1. Rather, our results indicate that this modification most
likely occurs in the cytoplasm, with the potential to activate
Cdr2 for additional layers of regulation.
As a final test of these spatial requirements, we forced the
interaction of Ssp1 and Cdr2 using theGBP (GFP-binding pep-
tide) system [4, 18, 19]. Ssp1 was recruited to cortical nodes incdr2-GBP-mCherry ssp1-mEGFP cells,
leading to increased levels of Cdr2-
pT166 (Figures 3E and 3F). This sug-
gests that, in the absence of a forced
interaction, cellular mechanisms exist
to limit Cdr2 activation by Ssp1. Sucha mechanism may also be linked to the increase of Cdr2-
pT166 levels as cells progress through the cell cycle.
Phosphorylation of Cdr2 Tail by Pom1 Inhibits Cdr2
Activation by Ssp1
Our results suggest that Ssp1 progressively activates Cdr2 as
cells increase in size and approach mitosis and division. This
contrastswith themitotic inhibitor Pom1, which forms a spatial
gradient that is proposed to inhibit Cdr2 in small cells but not in
large cells. Pom1 can phosphorylate Cdr2 both in vitro and in
cells [3], but the mechanisms that link this modification with
mitotic entry are unknown. To probe the connection between
Pom1 and Ssp1 in regulating Cdr2, we used a-pT166 to test
a panel of cell polarity mutants, including pom1D. In pom1D
samples, the double Cdr2-pT166 band was collapsed to a
single band, consistent with an upper Pom1-dependent
phosphoisoform (Figures 2A and S3A). The upper band also
depended on Tea4 (Figure S3A), which is required for forma-
tion of the Pom1 cortical gradient [20]. More importantly,
we consistently found increased signal for Cdr2-pT166 in
pom1D versus wild-type cell extracts. Using epitope-tagged
Cdr2 to normalize for total Cdr2 protein levels, we measured
a 3-fold increase in the level of Cdr2-pT166 in pom1D versus
wild-type cells (Figures 4A and 4B). This suggests the possibil-
ity that phosphorylation of the Cdr2 C-terminal tail domain by
Pom1 inhibits the activating pT166 modification in the Cdr2
kinase domain.
We tested this possibility further by mutating Pom1-depen-
dent phosphorylation sites in the Cdr2 CTD.We first generated
a cdr2-5A construct by mutating four Pom1 sites (S758, S760,
S761, and S762), as well as a nearby site (S755) that matches
Figure 4. Phosphorylation of Cdr2 C-Terminal
Tail by Pom1 Inhibits Cdr2 Activation by Ssp1
(A) Detection of Cdr2-pT166 in the indicated
strains.
(B) Quantification of Cdr2-pT166 levels for strains
in (A). Background was subtracted from the non-
tagged strain, and values were normalized to the
wild-type. Error bars indicate the SD in three bio-
logical repeats.
(C) Length of dividing, septated cells of the indi-
cated strains (mean 6 SD; n > 50 for each value).
The p values of two-tailed Student’s t tests are
indicated in brackets for interested pairs.
(D) Schematic of genetic pathway for Ssp1 and
Pom1.
(E) Model for cell-size-dependent regulation
of Cdr2-pT166 through activating cytoplasmic
Ssp1 and inhibitory Pom1 gradient.
See also Figure S3.
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432our Pom1 consensus (RXXpS). In addition, we deleted these
sites by generating a truncated cdr2DCTD construct. Similar
to pom1D, these mutations increased the levels of Cdr2-
pT166 at least 3-fold over the wild-type (Figures 4A and 4B).
We conclude that Pom1 prevents mitotic entry at least in
part by inhibiting the levels of activated Cdr2-pT166. If Pom1
acts through Cdr2-pT166, then Pom1 effects on cell size at di-
vision should require this modification. Indeed, pom1D cells
exhibit a reduced size at division, but we found that pom1D
had no effect on cell size when combined with cdr2-T166A.
Similarly, pom1Ddid not reduce the division size of ssp1D cells
(Figure 4C), which lack phosphorylation of Cdr2-T166. These
effects are not due to changes in protein localization, as no
localization dependency was observed between Pom1 and
Ssp1 (Figure S3B). Thus, Pom1 prevents the activating Cdr2-
pT166 modification by phosphorylating the Cdr2 C terminus,
and Pom1 cannot regulate cell size at division in the absence
of Cdr2-pT166 (Figure 4D).
These results indicate that Cdr2 integrates input signals from
Pom1andSsp1, leading to increasedCdr2-pT166ascellsgrow.
We propose that Ssp1 activates Cdr2 kinase activity by phos-
phorylating Cdr2-T166 to promote mitotic entry. In contrast,
Pom1 phosphorylates the Cdr2 CTD, and this modification re-
duces phosphorylation of Cdr2-T166 in the kinase domain.
These findings lead to a model in which the level of Cdr2-
pT166 is low in small G2 cells due to overlap between Cdr2 no-
des and the Pom1 polar gradient. As cells grow during G2,
reduced overlap between Pom1 and Cdr2 leads to increased
levels of Cdr2-pT166 and higher mitotic potential (Figure 4E).
An important next step will be to determine how phosphoryla-
tion of the Cdr2 CTD by Pom1 inhibits phosphorylation atT166. Phosphorylation by Pom1 might
generate a docking site for phospha-
tases to reverse Cdr2-T166 phosphory-
lation. We also note that the CTD of
several Cdr2-related proteins inhibits ki-
naseactivity [21–24], raising thepossibil-
ity of Pom1-dependent autoinhibition.
It is also possible that phosphorylation
of Cdr2-CTD by Pom1 regulates binding
by Ssp1. These models are not mutually
exclusive and indicate that additional
proteins are likely to contribute to this
regulatory cascade.Our data identify the conserved kinases Pom1 and Ssp1 as
master regulators in the coordination of cell growth and divi-
sion. The cytosolic localization of CaMKK Ssp1 is consistent
with a role in activating downstream targets for additional
layers of regulation. In contrast, the spatial gradient of Pom1
can tune the activity of downstream targets with changes in
cell growth and shape. These signals converge on a single
target in the SAD kinase Cdr2. This mechanism bears striking
similarity to the regulation of SAD kinases in axonal arbor for-
mation in mammals [25]. In these neurons, Cdk5 phosphory-
lates the CTD of SAD-A and SAD-B to inhibit activation by T
loop phosphorylation, although the activating kinase in these
neurons is unknown. Thus, CTD phosphorylation prevents T
loop activation of SAD kinases in diverse biological systems
such as neuronal morphogenesis and the yeast cell cycle.
We anticipate that future work will uncover additional inputs
and mechanisms that are integrated by this conserved class
of signaling molecules.
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, three figures, and two tables and can be found with this article online
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